PXR expression has been reported in both ER(+) and ER(−) cancers, with some studies stating that its expression negatively correlates with ER status, while others stressed that higher PXR expression associated with higher survival rates in ER(+) breast cancer patients [43]. This evidence concerns the gene NR1I2 and breast carcinoma.